a NR
Generic Name: divalproex sodium
Pill imprint a NR has been identified as Depakote 250 mg.
Depakote is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; hyperekplexia and belongs to the drug class fatty acid derivative anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Depakote 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Depakote Images
- Generic Name:
- divalproex sodium
- Imprint:
-
a NR
- Strength:
- 250 mg
- Color:
- Orange
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- povidone
magnesium silicate
titanium dioxide
vanillin
FD&C Yellow No. 6
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-6214
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-1208 | Physicians Total Care Inc (repackager) |
| 54569-0261 | A S Medication Solutions LLC (repackager) |
| 58016-0687 | Southwood Pharmaceuticals Inc (repackager) |
| 68115-0467 | Dispensexpress Inc (repackager) |
| 55045-2484 | Dispensing Solutions Inc. (repackager) |
| 33358-0100 | Core Pharmaceuticals Inc (repackager) |
| 16590-0587 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Depakote resources
- Depakote
- Depakote Delayed-Release Tablets (Wolters Kluwer)
- Depakote Sprinkle Capsules (Wolters Kluwer)
- Depakote (Cerner Multum)
- Depakote (Micromedex) - Includes Dosage Information
- Depakote (FDA)
Search Again
